Diabetes and cardiometabolic companies have marketing, clinical, and enrollment data that rarely connect. We create the measurement layer linking spend to qualified enrollment, retention, and outcomes – within the privacy constraints this category requires.
The Challenge
Clinical and marketing data exist in separate worlds
Ad platforms, the CRM, the eligibility system, and the clinical or engagement platform each hold part of the story, and nothing joins them. That means no one can trace a paid click to a qualified enrollment to a retained patient. Without that connected view, spend decisions are made on partial data, and the channels that produce lasting patients are indistinguishable from the ones that produce churn.
Privacy requirements make simplistic tracking a liability
Health data is sensitive, and the usual practice of piping identifiers into ad platforms and analytics tools can create real compliance exposure in this category. Teams either over-track and take on risk or under-track and fly blind. Building measurement that connects the funnel while respecting privacy boundaries is a discipline generic analytics setups ignore.
Vanity metrics obscure the numbers that truly matter
Pageviews, leads, and cost-per-click are easy to report and easy to celebrate, but they say nothing about whether a patient enrolled, qualified, activated, or stayed. Leadership ends up optimizing to numbers that do not move the business. Reporting has to elevate the downstream events – qualified enrollment and retention – over the top-of-funnel numbers that flatter a channel.
E-commerce attribution fails on long, gated journeys
Cardiometabolic patient journeys are long, involve eligibility and clinical gates, and often cross online and offline touchpoints, which most attribution models handle badly. Last-click or platform-reported conversions credit the wrong channels and misdirect budget. Measurement has to model the real, multi-step journey rather than borrow an e-commerce attribution default.
How We Help
We begin by identifying the events that genuinely matter – qualified enrollment, activation, retention, and the outcome milestones unique to your program – so the whole measurement system centers on them rather than clicks. This keeps reporting aligned with the [growth strategy](/services/strategy/) instead of an ad platform's defaults.
We bring disconnected systems together. Marketing, CRM, eligibility, and engagement data are combined into one view that follows a touchpoint through to a retained patient, allowing spend decisions to reflect the complete journey instead of fragments from separate tools.
We create that unified view within privacy constraints. Rather than sending health identifiers to ad platforms, we apply privacy-safe measurement methods that reveal channel performance without introducing the compliance exposure associated with naive tracking. Privacy and measurement are designed together, rather than balanced against one another.
We develop reporting that prioritizes the right metrics and supports the [measurement](/services/measurement/) practice. Dashboards put qualified enrollment and channel-level retention first, relegating vanity metrics to context so leadership optimizes around the events that sustain the business.
We model attribution around the actual journey. Instead of relying on last-click, we account for the long, gated, multi-touch path patients really follow, ensuring budget credit goes to channels that truly drive enrollment. This feeds trustworthy data back into [marketing](/services/marketing/) decisions.
We are not here to build more dashboards. We create a connected, privacy-safe measurement layer that answers the question that matters most: what generates a retained patient.
What we deliver
- A defined event model centered on qualified enrollment, activation, and retention
- A connected data view joining marketing, CRM, eligibility, and engagement systems
- Privacy-safe measurement that avoids piping health identifiers into ad tools
- Reporting that leads with downstream outcomes over vanity metrics
- An attribution model built for the long, gated patient journey
- Dashboards your team can operate to steer spend by retained-patient value
For diabetes and cardiometabolic health, the issue is rarely insufficient data – it is that marketing, eligibility, and clinical data remain disconnected, making a channel that creates a retained patient look the same as one that creates churn until a private layer joins them.
Our Methodology
Our 90-day sprint creates a connected, privacy-safe measurement layer instead of adding another dashboard. Days 1-30 center on definition and audit: we identify the events that matter to your model, catalog where marketing, CRM, eligibility, and engagement data reside, and establish the privacy boundaries all measurement must follow. This phase concludes with an event model and data architecture plan.
Days 31-60 establish the connection. We combine the systems into one view that links touchpoints to retained patients, introduce privacy-safe measurement that shows channel performance without revealing health identifiers, and launch reporting focused on enrollment and retention. Attribution reflects the actual gated journey rather than last-click.
Days 61-90 focus on validation and handoff. We test the numbers against known reality, fine-tune the attribution model, and document the measurement system so your team can manage and expand it. Since measurement compounds as data grows, the sprint provides a durable layer and the expertise to operate it, rather than a one-off report.
How We Work
During the first 30 days, we collaborate with your growth, data, and compliance leads because connecting the funnel while honoring privacy boundaries requires all three perspectives. Expect working sessions covering which events matter, where the data resides, and what tracking is or is not permitted.
Days 30-60 shift into building. Instead of delivering a KPI slide, we connect systems, introduce privacy-safe measurement, and establish reporting centered on enrollment and retention, with attribution based on the actual journey.
Days 60-90 emphasize validation and handoff. We reconcile the data with reality, refine attribution, and transfer the dashboards and documentation so your team controls the layer. Since measurement becomes more valuable as data accumulates, many engagements continue at a lighter cadence to expand the model when new channels and programs launch.
The team consists of a measurement strategist who owns the event model and reporting, an analytics engineer who connects systems and implements privacy-safe tracking, and a growth resource who ensures reporting meaningfully guides spend decisions.
- A connected view from touchpoint to retained patient
- Privacy-safe measurement that avoids compliance exposure
- Reporting that leads with enrollment and retention
- Attribution modeled for long, gated journeys
- Spend decisions based on retained-patient value, not clicks
If your diabetes & cardiometabolic health company needs data, reporting & analytics leadership, we should talk.
Expand your marketing team output with our experts
Let us take a custom approach to your growth goals by assembling and leading the best-in-class marketing team to support your next stage.
Frequently asked questions
What does a diabetes or cardiometabolic data, reporting, and analytics engagement cost?
Creating the measurement layer generally costs $12K-$30K/month throughout the engagement, based on the number of systems that must be connected and the complexity of privacy and attribution needs. Pricing is determined by the depth of data integration and modeling, not a set number of dashboards. Since this layer influences how every marketing dollar gets allocated, the investment is evaluated against greater spend efficiency rather than the price of a reporting tool.
Why is measurement more difficult for cardiometabolic companies than standard SaaS or e-commerce?
The patient journey is lengthy and gated by clinical and eligibility steps, while the key events are enrollment and retention rather than a purchase, and health-data privacy rules restrict the tracking methods most analytics setups depend on. Together, these factors undermine standard e-commerce attribution and naive pixel tracking. We design measurement for the actual journey and within its privacy constraints instead of imposing a generic setup.
How can you measure marketing performance without breaching health-data privacy?
We apply privacy-safe measurement methods that show channel performance without sending health identifiers into ad platforms, giving you the signal without creating compliance exposure. Privacy boundaries and measurement are designed together with your compliance team rather than handled as a tradeoff. The outcome is visibility into what works without introducing new liability.
How do you link marketing data with clinical and enrollment data?
We combine marketing, CRM, eligibility, and engagement systems into a unified view that follows a touchpoint through qualification to a retained patient while respecting privacy boundaries around identifier handling. This connected view reveals which channels generate lasting patients, not merely leads. It replaces fragmented reporting from individual tools that conceals the complete journey.
How does improved measurement meaningfully change our results?
When spend is connected to qualified enrollment and channel-level retention, budget shifts away from channels producing low-cost leads who churn and toward those generating patients who remain. Attribution based on the actual journey avoids rewarding the wrong touchpoints, leading to sharper decisions. The benefit appears in stronger acquisition economics, not simply a more attractive report.
What does it look like to get started with analytics?
We start by identifying the events that matter to your model, cataloging where your data resides, and outlining the privacy boundaries all measurement must follow. This creates an event model and data architecture plan before any building begins. If your diabetes or cardiometabolic company has dashboards but cannot identify which spend produces a retained patient, we should talk.
